About Global Medical Institutes

Providing Innovative Mental Health Treatment

Global Medical Institute, LLC (GMI) is an Investigative Research Company which conducts Phase I-IV human clinical trials for the pharmaceutical, biotechnology and medical devices industry through our network of wholly-owned and affiliated clinical research facilities. Each facility offers specialized care across a broad spectrum of therapeutic indications enrolling patients of diverse cultural and ethnic backgrounds. Our clinicians are all board certified within their area of expertise and are currently enrolling patients from their own private practice populations and the GMI clinical trial patient database.


​For more than a decade, GMI has conducted Phase 1 through 4 outpatient studies on behalf of major pharmaceutical companies such as Merck, inVentiv Health, AbbVie and Pfizer. Our caring and professional staff is comprised of Physicians, Nurses, Study Coordinators, Regulatory Specialists and Lab Technicians who are dedicated to providing the highest level of quality patient care.

 

Goals

​Initiating studies rapidly: Through our wholly-owned, site network we offer individual or group contracting services depending on the needs of our clients. Whether you choose to work with one or all of our quality sites, we commit to an efficient and hassle-free experience.

Simplifying the Process: All of our sites offer the use of a Central Institutional Review Board of Sponsor choice. This allows for timely regulatory submissions. Se also can assign a centralized Project Manager to facilitate the IRB interaction and oversee each trial regardless of the site used to ensure quality and compliance, while maintaining consistent communication to the sponsor.

Accelerating the conduct:  The GMI Investigators accelerate enrollment and study completion through involvement of their own private practice patients in the clinical research opportunity. In addition GMI has accumulated a robust computerized patient data base over the last decade of work which identifies prospective study participants by indication and age.

Improving the reliability and accuracy: All of the sites in the GMI network follow the same company-wide Standard Operating Procedures and investigator and coordinator training and quality programs. All of our study coordinators are members of ACRP and several of them are certified Clinical Research Coordinators (CCRC’s). Our centralized regulatory office monitors all IRB submissions from every trial and site as well as maintains our Standard Operating Procedures and training logs. 

 


Lead Investigator

Dr Jeffrey T. Apter is the Founder and President of Global Medical Institutes and is the Lead Principal Investigator for PMI. He has been a research collaborator in the Departments of Psychology and Molecular Biology at various educational institutions around the world. Dr. Apter has published over 30 articles in the areas of psychiatric and Alzheimer’s research in conjunction with Princeton University.

Click here for more information about Dr. Apter.

Contact Us Today

Clinical Treatments Include:

Call Today to Schedule a Consultation

Ready to join one of our ground-breaking studies? Book your consultation today to speak with one of our expert representatives.